Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
USANA USNA Stock 52Week High Institutional Demand 20260416 Should I sell Foghorn Therapeutics FHTX stock today Q4 2025 Earnings Underperform TX Ternium SA posts 36 percent Q4 2025 EPS miss yet shares edge slightly higher in trading today ProShares Ultra VIX ShortTerm Futures ETF UVXY Included in ProShares November 2025 Batch of 22 Leveraged and Inverse ETF Share Splits NAC Nuveen reports quarterly results California municipal bond fund maintains focus on taxfree income distribution stability ChurchDwight CHD Stock Volume Stability RangeBound 20260420 UVE UNIVERSAL Q4 2025 earnings beat estimates by 65 percent revenue rises 55 percent year over year State Street SPDR SP Software Services ETF XSW 2026 Investment Merit Assessment for Technology Sector Exposure What Arcellx ACLX subscription metrics reveal about retention Q4 2025 EPS Tops Views How Sprinklr CXM benefits from the shifts in its industry Gains 20260508 ConocoPhillips COP Valuation Assessment Amid Recent Share Price Pullback and LNG Growth Tailwinds Brace for the Most Volatile Summer at the Pump in Years Analysts Warn Labor Market in Focus What the April Jobs Report Signals for the US Economy Trump Leaves China After HighStakes Talks on Trade Oil and Taiwan ICU Medical Inc ICUI Shows Measured Gains as Shares Test Key Resistance Levels GM Unveils AllElectric Cadillac Vistiq Targeting 300Mile Range Bloom Energy Surges 12 on 26 Billion AI Infrastructure Deal with European Cloud Provider Nebius EU Imposes 230 Million Fine on Temu Over Illegal Product Sales Inflation Squeeze Travel Recreation and Food Prices Surge Ahead of Memorial Day Weekend London Stock Exchange Group Reports Income Growth Driven by Tradeweb Performance Singapores STI Edges Up 04 as Keppel Leads Gains Geopolitical Caution Persists Rubrik Inc RBRK Q1 2026 Earnings Strong EPS Surprise Signals Operating Leverage i3 Verticals Q1 2026 Earnings EPS Surpasses Estimates Stock Rises 173 Immunovant IMVT Q1 2026 Earnings NarrowerThanExpected Loss but EPS Miss Highlights RD Spending CLIR Q1 2026 Earnings WiderthanExpected Loss Reflects Continued PreRevenue Development MLYS Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Ahead of Key Trial Data EH Q4 2025 Earnings Significant EPS Surprise Highlights Progress in eVTOL Commercialization